Adaptive Biotechnologies CorporationADPTNASDAQ
LOADING
|||
Switch Symbol:
Year-over-year revenue growth rate
| Period | Value |
|---|---|
| Q3 2025 | 59.60% |
| Q2 2025 | 12.27% |
| Q1 2025 | 10.50% |
| Q4 2024 | 2.21% |
| Q3 2024 | 7.51% |
| Q2 2024 | 3.15% |
| Q1 2024 | -8.54% |
| Q4 2023 | 20.74% |
| Q3 2023 | -22.50% |
| Q2 2023 | 29.96% |
| Q1 2023 | -31.80% |
| Q4 2022 | 15.40% |
| Q3 2022 | 9.55% |
| Q2 2022 | 13.05% |
| Q1 2022 | 1.82% |
| Q4 2021 | -3.89% |
| Q3 2021 | 2.50% |
| Q2 2021 | 0.16% |
| Q1 2021 | 27.35% |
| Q4 2020 | 14.78% |
| Q3 2020 | 25.30% |
| Q2 2020 | 0.37% |
| Q1 2020 | -13.63% |
| Q4 2019 | -7.10% |
| Q3 2019 | 17.71% |
| Q2 2019 | 74.78% |
| Q1 2019 | -26.33% |
| Q4 2018 | 0.02% |
| Q3 2018 | 48.58% |
| Q2 2018 | 19.07% |
| Q1 2018 | 0.00% |